European Due Diligence Summit for Life Sciences -

European Due Diligence Summit for Life Sciences
26–27 February 2018
London, United Kingdom

Conduct efficient and effective due diligence on licensing deals, acquisitions, and strategic alliances

Agenda – European Due Diligence Summit for Life Sciences



Day 1

 Monday, 26 February 2018

8:45 – 9:00

Chairperson’s Opening Remarks


Mike Myers, Senior Director, Lilly Research Labs — Due Diligence, ELI LILLY

9:00 – 9:45

Guidelines for Developing an Efficient and Targeted Due Diligence Plan


Chris Davie, Executive Director, Diligence, MUNDIPHARMA

9:45 – 10:30

Centre of Excellence: An Organisational Model for Driving Continuous Improvement in Due Diligence Practice


Gareth Ayre, Head Centre of Excellence, Due Diligence, NOVARTIS

10:30 – 11:00

Networking Break


11:00 – 11:45

Best Practice in Developing a Focused Intellectual Property Due Diligence Process


Steven Gurney, Principal Associate and Patent Attorney, MARKS & CLERK
Will James, Partner and Solicitor, MARKS & CLERK

12:30 – 13:30

Luncheon


13:30 – 14:15

Identify Negotiation Factors That Can Impact the Purchase Price and Deal Structure of a Transaction


If you are interested in leading this session, please contact Andrew Sinetar at asinetar@exlevents.com.

14:15 – 15:00

PANEL: Understand How to Make a Deal More Attractive to Investors


Lubor Gaal, Ph.D., Head of External Innovation and Licensing, ALMIRALL
Austin Doyle, Ph.D., FRSB, Director, Science and Technology Licensing, R&D Worldwide Business Development, GSK
Carl Jessop, FRQA, Due Diligence Director, Business Development, ASTRAZENECA

15:00 – 15:30

Networking Break


15:30 – 16:15

Partnerships, Prioritisation and Diligence


Nick Clarke, Ph.D., Head of U.K. Academic Partnerships, External Science and Innovation, PFIZER

16:15 – 17:00

Interactive Learning Discussion: Discover How Your Peers Conduct Due Diligence at Their Organisations


Mike Myers, Senior Director, Lilly Research Labs — Due Diligence, ELI LILLY


Day 2

 Tuesday, 27 February 2018

9:00 – 9:15

Chairperson’s Recap of Day One


Mike Myers, Senior Director, Lilly Research Labs — Due Diligence, ELI LILLY

9:15 – 9:45

Successfully Run a Gap Analysis to Determine the Development Costs and Future Sales for an EarlyStage Asset


Marco Cerato, Head of BD&L, Late-Stage and Marketed Products, HELSINN

9:45 – 10:30

Case Study: Considerations for Selecting a Marketing or Promotion Partner That Is Right For Your Product


Roland Pfeiffer, Ph.D., Head Commercial Development Europe, VIFOR PHARMA

10:30 – 11:00

Networking Break


11:00 – 11:45

Virtual Due Diligence and How to Successfully Leverage Data Rooms


John Easton, Ph.D., Head of Business Operations, Business Development, ASTRAZENECA

11:45 – 12:30

Panel: Effective Strategies for Working With External Advisors and Consultants


Cristiano Musso, Chief Business Officer, CIRCASSIA

12:30 – 13:15

Luncheon


13:15 – 14:00

Integration Management: The Challenge of Avoiding Value Deprivation of a Deal Post-Due Diligence


Robert Bauer, Ph.D., Director, Business Development EMEA, SANTEN

14:00 – 14:45

Case Study: Recognising and Challenging Bias in Navigating Portfolio Decision-Making


Mike Myers, Senior Director, Lilly Research Labs — Due Diligence, ELI LILLY


live chat software